Literature DB >> 19700401

Effects of stability on the biological function of p53.

Kian Hoe Khoo1, Sebastian Mayer, Alan R Fersht.   

Abstract

The core domain of the tumor suppressor p53 has low thermodynamic stability, and many oncogenic mutations cause it to denature rapidly at body temperature. We made a series of core domain mutants that are significantly less or more stable than wild type to investigate effects of stability on the transcriptional activity and levels of native full-length p53 in H1299 mammalian cells. The levels of transcriptionally inactive native protein with inactivating mutations in the N-terminal transactivation domain correlated strongly with stability. The levels of transcriptionally active proteins, however, depended on both their stability and the transcriptional activity that leads to the feedback loop of proteolytic degradation via transcription of E3 ligases. A very highly stabilized quadruple mutant and an even more stable hexamutant were more active than wild-type p53 in terms of Bax transcription and apoptotic activity, and reached higher levels than wild type in cells. The increased activity did not result from increased overall stability but was due to a single known suppressor mutation, N239Y. It is possible that the low intrinsic stability of p53 is a means of keeping its level low in the cell by spontaneous denaturation, by a route additional to that of proteolytic degradation via E3 ligase pathways. Denatured p53 does accumulate in cells, and there are pathways for the proteolysis of denatured proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700401      PMCID: PMC2781498          DOI: 10.1074/jbc.M109.033183

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.

Authors:  P V Nikolova; K B Wong; B DeDecker; J Henckel; A R Fersht
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.

Authors:  R Candau; D M Scolnick; P Darpino; C Y Ying; T D Halazonetis; S L Berger
Journal:  Oncogene       Date:  1997-08-14       Impact factor: 9.867

4.  The p53-mdm-2 autoregulatory feedback loop.

Authors:  X Wu; J H Bayle; D Olson; A J Levine
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

Review 6.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

7.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

8.  A temperature-sensitive mutant of human p53.

Authors:  W Zhang; X Y Guo; G Y Hu; W B Liu; J W Shay; A B Deisseroth
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

9.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

Review 10.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; J Y Wang; G Melino
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  6 in total

1.  Kinetics and longevity of ΦC31 integrase in mouse liver and cultured cells.

Authors:  Christopher L Chavez; Annahita Keravala; Lauren E Woodard; Robert T Hillman; Timothy R Stowe; Jacqueline N Chu; Michele P Calos
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

2.  Identification of two reactive cysteine residues in the tumor suppressor protein p53 using top-down FTICR mass spectrometry.

Authors:  Jenna Scotcher; David J Clarke; Stefan K Weidt; C Logan Mackay; Ted R Hupp; Peter J Sadler; Pat R R Langridge-Smith
Journal:  J Am Soc Mass Spectrom       Date:  2011-02-24       Impact factor: 3.109

3.  The calcium-binding protein S100B reduces IL6 production in malignant melanoma via inhibition of RSK cellular signaling.

Authors:  Milad J Alasady; Alexander R Terry; Adam D Pierce; Michael C Cavalier; Catherine S Blaha; Kaylin A Adipietro; Paul T Wilder; David J Weber; Nissim Hay
Journal:  PLoS One       Date:  2021-08-19       Impact factor: 3.240

4.  A single mutant, A276S of p53, turns the switch to apoptosis.

Authors:  Shams Reaz; Mohanad Mossalam; Abood Okal; Carol S Lim
Journal:  Mol Pharm       Date:  2013-03-01       Impact factor: 4.939

5.  Folding of a cyclin box: linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor AB pocket domain.

Authors:  Lucía B Chemes; María G Noval; Ignacio E Sánchez; Gonzalo de Prat-Gay
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

6.  The gain of function of p53 mutant p53S in promoting tumorigenesis by cross-talking with H-RasV12.

Authors:  Shuting Jia; Lanjun Zhao; Wenru Tang; Ying Luo
Journal:  Int J Biol Sci       Date:  2012-04-18       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.